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A B S T R A C T   
Background: Several diseases associated to colon microbial imbalance (dysbiosis), such as obesity, diabetes, in-
flammatory bowel disease, cardiovascular disease and cancer, are being reverted by modulation of gut micro-
biota composition through treatment with prebiotics and probiotics. Multiple in vitro models have been 
developed over the past three decades, with several experimental configurations, as they provide a quick, easy, 
and cost-effective approach to study the gut microbiome, as compared to troublesome and time-consuming in 
vivo studies. 
Scope and approach: This review aims to provide an overview of the most relevant available in vitro models used 
to mimic the human colon microbiome dynamics, including macro-scale and microfluidic-based models. Main 
characteristics, functionalities, current applications and advantages or disadvantages of the models are discussed 
in order to provide useful information for end users (namely food and pharmaceutical researchers), when 
selecting the most appropriated model for assessing health claims and safety of novel functional food and drugs. 
Finally, the use of these colon models as a tool to study prebiotic and probiotic response in host-microbiota 
interaction is reviewed. 
Key findings and conclusions: A wide range of in vitro models representing specific colon parts have been devel-
oped. However, none of these models can simultaneously cover all the key conditions found in the human colon 
(namely anatomical, physical, biochemical, and biological characteristics), as well as the complex microbiome- 
host interaction. Thus, there is a significant opportunity for further improvement of the models’ experimental 
setups towards more realistic operating systems, including mucosal surfaces, intestinal cells and tissues allowing 
microbiome–host crosstalk representation.   
1. Introduction 
The human gastrointestinal (GI) tract harbours the highest micro-
organisms’ diversity of the human body ecosystem. Numerous studies 
have pointed out the significance of the microbial community structure 
in the GI tract (Liang, Leung, Guan, & Au, 2018; Proctor et al., 2019), as 
well as its contribution to homeostatic processes, including protein and 
amino acid synthesis (Neis, Dejong, & Rensen, 2015), vitamin biosyn-
thesis (Magnúsdóttir, Ravcheev, De Crécy-Lagard, & Thiele, 2015), 
carbohydrate metabolism, short chain fatty acids (SCFA) fermentation 
(Bach Knudsen, 2015) and host immune system development (Azad, 
Sarker, & Wan, 2018; Rajput & Li, 2012). Intestinal microorganisms 
closely interact with the host and play a key role on its health (von 
Martels et al., 2017). Moreover, changes on gut microbiota structure and 
function have a direct influence on therapeutic intervention 
(Vázquez-Baeza et al., 2018). Therefore, these complex microbial com-
munities have become a major research focus, since evidence increas-
ingly suggests their pivotal role in host’s health and disease. 
In vivo trials have been conducted to detect changes in human gut 
microbiota growth and metabolism response to diseases, dietary in-
terventions and drug treatments. However, these human trials pre-
dominantly rely on endpoint data alone, usually derived from faecal 
samples, since there are many constraints related to biopsies in different 
gut regions. This scenario prevents the dynamic follow-up of the gut 
microbiota effects along the GI tract (May, Evans, & Parry, 2017; Wil-
liams et al., 2015). Human and animal models are often impaired by 
inter-individual differences related to an endless list factors, such as age, 
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sex, diet, geography, genetic background, and use of antibiotics (May 
et al., 2017; Venema & Van Den Abbeele, 2013; Vermeiren, Possemiers, 
Marzorati, & de Wiele, 2011). Thus, more effective alternatives are 
required to study GI microbial community dynamics. 
In vitro models are extremely useful tools, especially to the food in-
dustry, to investigate the effects of food, novel food and functional food 
in the human microbiota, allowing to validate health claims and eval-
uate food safety. They provide a quick, easy, and cost-effective means of 
studying the gut microbiome dynamics, in one or more gut zones (May 
et al., 2017; Venema & Van Den Abbeele, 2013; Vermeiren et al., 2011). 
A wide range of setups are available, including pure cultures, over-
simplified single vessels batch cultures or more complex single- or 
multi-stage pH-regulated continuous cultures (Williams et al., 2015). 
These in vitro models enable monitoring changes in microbiota and its 
metabolism. Various relevant physiological conditions can be simulated, 
such as gut peristaltic movement, mucus layer and intestine cells, 
bringing these models one step closer to mimic in vivo conditions. 
Nevertheless, these in vitro models do not always provide accurate 
simulation of in vivo conditions, as they lack the real-time interaction 
with host intestinal mucosa, immune system, and endocrine functions 
(Boureau, Hartmann, Karjalainen, Rowland, & Wilkinson, 2000). The 
main advantages of the in vitro models are: a) being tightly controlled 
under reproducible conditions; b) allowing detailed mechanistic anal-
ysis; c) having limited ethical restrains; and d) requiring no expensive 
time-consuming procedures (as required for animal and human clinical 
trials) (von Martels et al., 2017). 
The main objective of this review is to provide significant informa-
tion regarding the most relevant in vitro models used to simulate the 
colon, including macro-scale and microfluidic-based models (so-called 
organ-on-a-chip). A summary of the human colon fundamental 
morphology is provided. Also, a critical analysis of the models’ design, 
setup (e.g. flow rates, mixing and feeding conditions), characteristics, 
applications, and advantages or disadvantages are discussed. Finally, the 
use of these colon models as a tool to study prebiotic and probiotic 
response in host-microbiota interaction is reviewed. 
2. Brief overview on human colon morphology 
The GI system consists of a series of hollow organs, from the mouth to 
the anus, associated with several accessory glands that add secretions to 
these organs. The GI tract is responsible for food digestion and absorp-
tion – after ingestion, food is digested, nutrients are released and 
absorbed, and the residues are expelled as faeces. The GI system is 
divided into four concentric layers: mucosa, submucosa, muscularis 
extern and serosa, from the inner to the outer layer. The myenteric 
plexus situated between the circular and longitudinal muscle layers, 
forms the enteric nervous system along with the submucosal plexus. The 
enteric nervous system is responsible for the motor and secretory ac-
tivity. It can be modulated by the autonomic nervous system (sympa-
thetic branch and parasympathetic branch). The motor activity includes 
peristalsis (coordinated contraction of the muscle layers), sphincters 
(high pressure muscles) and segmental contractions. The muscle activity 
is initiated by pacemaker cells named cells of Cajal. Additionally, the GI 
tract contributes to immune function of the human body (Hounnou, 
Destrieux, Desmé, Bertrand, & Velut, 2002; Stranding, 2016). 
The large intestine is a part of the lower GI tract and it lies between 
the small intestine and the anus. It is subdivided into cecum, ascending 
colon, transverse colon, descending colon and sigmoid colon (Fig. 1). 
The large intestine reabsorbs fluids and electrolytes and stores the faecal 
matter before its expulsion from the body. The proximal colon has two 
types of motor activity: non-propulsive segmentation and mass peri-
stalsis. The segmental contractions promote a mixing phase and give to 
the colon its typical appearance of haustra. During this motor activity, 
material is retained in the proximal colon for long periods, which allows 
fluids and electrolytes absorption. Mass peristalsis occurs one to three 
times a day, frequently stimulated by eating – the haustra disappear and 
a portion of the colonic content is propelled distally more than 20 cm 
(Boron & Boulpaep, 2016). 
Regarding the histology, the large intestine has a specialized 
epithelial structure that correlates well with its transport function. The 
cells lining the large intestine are surface epithelial cells, and inter-
spersed over the colonic surface, are numerous apertures of colonic 
crypts. The surface epithelial cells of the large intestine are the primary 
cells responsible for colonic electrolyte absorption, whereas colonic 
crypt cells are generally believed to mediate ion secretion. Some intes-
tinal cells secrete mucus that forms a double mucus layer, which re-
inforces the intestinal barrier and promotes favourable niches for 
bacteria colonization (Labarthe et al., 2019). Gut fluid absorption is 
usually defined as 1.9 L/day and it is calculated as the difference be-
tween ileocecal flow (approximately 2.0 L/day) and stool water 
(approximately 0.1 L/day) (Cremer, Arnoldini, & Hwa, 2017). The in-
formation on the physical parameters of the different colon segments is 
essential to understand the bacterial growth dynamics. Fig. 1 summa-
rizes the most important features regarding gut parameters (Boron & 
Boulpaep, 2016; Cremer et al., 2017; Moore, Dalley, & Agur, 2014). 
Gut bacteria represent around 70% of the human microbiota. Their 
primary location in the colon relates to their main function – soluble 
fibres not completely broken down by human digestive enzymes are 
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fermented in the colon by gut bacteria. The colon microbiome can be 
described regarding its taxonomic composition, i.e., the relative abun-
dance of microorganisms classified, for example in phyla, genera or 
species. Taxonomically, the colon microbiota of healthy humans is 
dominated by the bacterial phyla Firmicutes followed by Bacteroidetes 
(both accomplish 90% of the colon microbiome), Actinobacteria and 
Proteobacteria (Das & Nair, 2019). The Firmicutes/Bacteroidetes ratio 
(around 5/20 in healthy adults) represents an important marker of the 
microbiome homeostasis, since it is related to age and to the aetiology of 
some diseases like obesity and autism (Das & Nair, 2019; Mariat et al., 
2009). 
The predominant genus in the colon is Bacteroides. Metagenomics 
analysis of microbiota from United Kingdom and United States of 
America donors identified that 8 of the 20 most prevalent bacteria were 
from the same Bacteroides genus (Bacteroides vulgatus, Bacteroides uni-
formis, Bacteroides cellulosilyticus, Bacteroides ovatus, Bacteroides xylani-
solvens, Bacteroides thetaiotaomicron, Bacteroides caccae and Bacteroides 
dorei) (Forster et al., 2019). There are also some minority genera like 
Lactobacillus and Enteroccocus that are important markers of health/-
disease (Mariat et al., 2009). For example, the minor abundant but much 
relevant species from the phyla Verrucomicrobia (such as Akkermansia 
muciniphila) prevents high fat diet induced overweight (Das & Nair, 
2019; Mariat et al., 2009). 
The individual human colon microbiota is related with various fac-
tors such as age, diet, ethnicity, and geography (Liang et al., 2018; Priya 
& Blekhman, 2019). Furthermore, even at lower levels of the taxonomic 
classification, microbiota composition changes from person to person 
(Priya & Blekhman, 2019). The evolutionary forces shape the micro-
biota, which affect its adaptation within the microbial community. This 
adaptive behaviour impacts their long-term persistence in the gut, 
thereby influencing host health (Liang et al., 2018; Priya & Blekhman, 
2019). 
The complex gut microbiota dynamics encompass all its fundamental 
factors, such as fluid mechanic physics, dietary fibre degradation, 
epithelial motility and peristalsis connected to the bacteria population 
dynamics and the spatiotemporal digestion mechanisms. However, as 
identified by Labarthe et al. (2019), the key drivers of the colon 
microbiota biogeography can be comprehended as: a) viscosity gradi-
ents that allow the creation of favourable niches in the vicinity of the 
mucus layer; b) epithelial motility, preponderant for the colonization of 
the ascending colon; c) in the transverse colon, fibre levels and 
chemotaxis have the strongest impact on the microbial communities 
distribution; and d) residual dietary fibres that are the main driver of the 
microbiota spatial structure in the descending bowel. 
The microbiome can be described regarding its functionality, since 
most microorganisms have carbohydrate and amino-acid metabolism 
that plays an important role for the host’s nutrition, along with some 
functions that are restricted to a species or strain, including pathoge-
nicity, vitamin and drug catabolism, motility and nutrient transporters 
(Lozupone, Stombaugh, Gordon, Jansson, & Knight, 2012). The micro-
biome has a core set of genes that sustain its physiology and the healthy 
microbiome–host interactions despite the many observed variations 
related with e.g. age, ethnicity and diet. However, microbiome functions 
are determined more by this core set of genes than its taxonomic profile. 
In fact, some functions are related with low-abundant bacteria i.e. some 
functions derived from proteins expressed by genes that are specific 
from certain species or strains (Arumugam et al., 2011). In this sense, the 
human microbiome can be classified in bacteria clusters regrouped by 
functions (so-called enterotypes) that include different genera: a) 
Enterotype I ferments mainly carbohydrates through glycolysis and 
pentose phosphate pathways, holding high Bacteriodes proportion; b) 
Enterotype II is represented mostly by Prevotella, that degrades mucin 
glycoproteins; and c) Enterotype III includes other bacteria that effi-
ciently bind and hydrolyse the mucus layer, being mostly represented by 
Ruminococcus. Therefore, enterotypes are mainly defined by diet (Aru-
mugam et al., 2011; Rinninella et al., 2019). 
In summary, the gut’s anatomy and morphology create an environ-
ment that influences the microbiota biogeography throughout physical 
forces, while the substrates (e.g. dietary fibres and bioactive compounds) 
are the main factors driving its composition and function. Since the 
microbiota-host crosstalk is essential for maintaining a health-disease 
balance, and its mechanisms and intricacies are not well understood, 
there is a need to overcome methodological challenges to better un-
derstand microbiome complexity. Therefore, in vitro models that prop-
erly simulate human microbiome environment, its functions and 
interactions with human cells and tissues are required. 
3. In vitro colon models as a tool to study microbial communities 
In vitro colon models have been developed to simulate microbiota 
activity. These models range from simple single vessels to complex series 
of tailor-made bioreactors able to mimic one or several colon zones. 
These models allow researchers to observe and measure real-time effects 
on the gut microbiome. Current models can be broadly grouped ac-
cording to: 1) system dynamics (batch cultures vs continuous cultures); 
2) the number of represented colon regions (single vs multi-stage); and 
Fig. 1. Main physical colonic parameters (Data collected from Cremer et al., 2017; Moore et al., 2014; Boron & Boulpaep, 2016).  
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3) the inclusion of human cells to study microbiota–host interactions (e. 
g. intestine epithelium and immune system). 
Most relevant in vitro human colon models available are summarized 
in Fig. 2. They will be discussed in the following sections, regarding its 
usefulness, versatility, applications, and unique insights into the mi-
crobial ecosystem. 
Table 1 provides an overview on the experimental setup, culture 
protocols and growth media that have been used in the different in vitro 
colon systems, while highlighting the main advantages and disadvan-
tages of each model. 
3.1. Batch cultures 
Batch cultures are the simplest in vitro models used to study the 
human gut microbiota. They are mainly applied to assess specific sub-
strates metabolization by selected strains or complex faecal microbial 
communities (Venema & Van Den Abbeele, 2013). Usually, batch cul-
tures are run in single bioreactor vessels, containing basal media sup-
plemented with a specific substrate or a growth inhibitor. Operational 
conditions such as constant physiological temperature (37 ◦C) and 
anoxic atmosphere (generally by flushing N2) are applied. Typically, 
assays are run for short periods of time (24 h–48 h and a maximum of 72 
h) (El Oufir et al., 2000; Rumney & Rowland, 1992) (Table 1). Microbial 
communities, pure cultures or faecal material suspensions, are inocu-
lated into the sterile media to initiate fermentation, with or without pH 
control and without additional supply of nutrients. 
These models are used to study the effect of different substrates on 
the gut microorganisms’ physiology and biodiversity. The impact on the 
microbiota is evaluated by quantitative and qualitative molecular 
techniques, and the impact on metabolic activity is assessed by analysis 
of the SCFA released, as well as other metabolites. Batch models are 
appropriate to check inter-individual variability in response to a 
particular bioactive compound or agent, and to compare consequences 
of exposure to different compound sources or doses. In addition, they 
provide a first assessment on microbial metabolites formed and help to 
elucidate metabolic pathways involved (Verhoeckx et al., 2015). 
The advantages of batch cultures include quick assembling, inex-
pensive running, easy operation and reproducibility, as a result of 
overall setup design simplicity. The high throughput and potential 
automation features make them almost an initial mandatory method to 
investigate gut microbiota composition, metabolism, and modulation by 
probiotics and diet compounds. Since these models are easily down-
scaled, the required media volume and test compounds concentration 
may be reduced. Batch cultures are usually employed before conducting 
more complex multi-vessel continuous fermentation experiments (Wil-
liams et al., 2015). 
The main disadvantages of the batch cultures are the rapid substrate 
depletion, the high accumulation of microbial metabolites and the me-
dium acidification, which prevents further microbial activity and 
operation under longer operation times (in average, fermentations are 
run up to 48 h) (Payne, Zihler, Chassard, & Lacroix, 2012; Venema & 
Van Den Abbeele, 2013). For this reason, the distal colon is usually 
modelled on these systems at pH 6.8. The simulation of more complex GI 
functionalities, such as peristalsis, is not possible in these models. Lastly, 
short term fermentations may prevent the establishment of trophic 
chain, where metabolites produced by some species become the sub-
strate of other species (Pham & Mohajeri, 2018). 
3.2. Continuous single-stage culture models 
Continuous Single-Stage Culture models (CSSC) are based on original 
in vitro semi-continuous cultures developed to investigate rumen mi-
crobial communities by Rufener, Nelson, and Wolin (1963) and Slyter, 
Nelson, and Wolin (1964), as well as Pirt’s fed batch cultures (Pirt, 
1974). These models have been used to culture complex microbial 
communities, such as those found in faeces (McDonald et al., 2013, 
2015), and more simple cultures, such as defined bacterial communities 
(Drake & Brogden, 2002; Newton, MacFarlane, & MacFarlane, 2013). 
CSSC are often designed to simulate the proximal colon conditions, 
reproducing its metabolic activity. 
CSSC systems are physiologically more relevant than batch cultures. 
They provide a constant nutrients influx and waste products efflux over 
a defined retention time, which enables continuous operation. In fact, 
these models allow to run experiments for several days or months, due to 
the continuous monitoring and correction of several parameters 
including pH, temperature, nutrient input, and waste removal (Drake & 
Brogden, 2002). The stable environment enables growing complex 
bacterial communities up to a steady state. In addition, the chemostat 
model provides tightly controlled atmospheric conditions and re-
produces the GI tract anaerobic environment, offering ideal conditions 
for fastidious anaerobic organism culture. CSSC systems can be pro-
grammed to monitor atmospheric oxygen levels, and continuously flush 
N2 into each vessel to create the desired anaerobic environment (Drake 
& Brogden, 2002). 
The main disadvantage of the CSSC models is that, generally, only a 
single colon zone is simulated, lacking information on the microbial 
dynamics behaviour along the GI tract. This prevents the identification 
of relevant patterns and mechanisms taking place in the different colon 
zones, which may hinder a comprehensive understanding of the phe-
nomena under study. 
Most relevant examples of CSSC are briefly described in the 
following sub-sections. 
3.2.1. Twin-vessel single-stage chemostats system 
The Twin-Vessel Single-Stage Chemostats system (TVSC) was 
developed to simulate the distal colon. Two similar vessels run simul-
taneously, allowing to test different conditions on the same inoculated 
sample (McDonald et al., 2013). One vessel is usually used as a test 
Fig. 2. Overview of relevant in vitro colon models currently used to study the gut microbiota.  
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Table 1 
Overview of the operational conditions, growth media, advantages and disadvantages of in vitro colon systems.  
Gut Model Operational Conditions Growth Media Advantages Disadvantages 
Batch Cultures (Takagi 
et al., 2016) 
GI Simulated Section: Colon 
Inoculum: Human faecal samples 
Gas Mixture: N2 and CO2 (80:20) 
Temperature: 37 ◦C 
Stirring: 300 rpm 
pH: 6.5 
Working Volume: 100 mL 
Gifu anaerobic broth pH 6.5 supplemented with 
fructooligosaccharides, galactooligosaccharides, 
isomaltooligosaccharides, xylooligosaccharides, 
raffinose, lactulose or lactosucrose  
- Fast, cheap, easy to 
operate, and reproducible  
- Small quantities of testing 
compounds  
- Reduced cost  
- Closed systems  
- Less risk of contamination  
- Short culture periods  
- Nutrients decrease 
over time  
- Limited amount of 
growth media  
- Build-up of waste 
products  
- Lack of environment 
control 
Twin-Vessel Single Stage 
Chemostats (McDonald 
et al., 2013, 2015) 
GI Simulated Section: Distal 
colon 
Inoculum: Human faecal samples 
Gas Mixture: N2 
Temperature: 37 ◦C 
pH: 6.9–7.0 
Working Volume: 400 mL 
Feed flow rate (medium): 400 
mL/d 
-Vessels were allowed to run for 
48 d post-inoculation 
Peptone water, yeast extract, NaHCO3, CaCl2, 
pectin, xylan, arabinogalactan, starch, casein, 
inulin, NaCl2, KH2PO4, MgSO4, hemin, menadione, 
bile salts, L-cysteine, porcine gastric and mucin  
- Reproducibility  
- Long period of culture  
- Perturbation studies  
- Simultaneous control can 
be monitored  
- Risk of 
contamination due to 
daily operation  
- Anatomy of intestine 
not mimicked  
- Long operation 
increases the cost per 
run  
- No host cells 
MBRAs (Auchtung et al., 
2015; Robinson et al., 
2014) 
GI Simulated Section: Distal 
colon 
Inoculum: Human faecal samples 
Gas Mixture: 5% H2 – 5% 
CO2-90% N2 
Temperature: 37 ◦C 
Stirring: magnetic stir plates 
pH: 6.8 
Working Volume: 15 mL 
Waste removal flow rate: 1.875 
mL/h 
Tryptone, proteose peptone, yeast extract, 
arabinogalactan, maltose, D-cellobiose, NaCl, 
hemin, MgSO4, CaCl2, KH2PO4, phosphate dibasic, 
tween 80 pH = 6.8, bovine bile, D-glucose, inulin, 
sodium bicarbonate and vitamin K3  
- Small processing volumes  
- Reduced cost per run  
- Up to 48 systems 
operating simultaneously  
- Reaches steady state 
faster  
- Only simulates 
proximal region of 
the colon  
- Inhibition of growth 
by excess of end 
products  
- No host simulation 
P-ECSIM (Brugere et al., 
2011; Feria-Gervasio 
et al., 2011) 
GI Simulated Section: Proximal 
colon 
Inoculum: Glycerol stocks of 
human faecal samples 
Gas Mixture: N/A, anaerobic 
conditions maintained by 
microbial metabolism 
Temperature: 37 ◦C 
Stirring: 400 rpm 
pH: 5.75 
Working Volume: 2 L 
Retention Time: Short one =
12.5 h and Longer one = 25 h 
Mucin, starch, pectin, guar gum, xylan, 
arabinogalactan, inulin, L-cystein, HCl, casein, 
peptone, tryptone, yeast extract, bile salts, tween 
80, FeSO4, NaCl, KCl, KH2PO4, MgSO4, CaCl2, 
NaHCO3, hemin, MnSO4, FeSO4, CoSO4, ZnSO4, 
CuSO4, AlK(SO4), H3BO3, Na2MoO4, NiCl2, 
Na2SeO3, menadione, D-biotin, pantothenate, 
nicotinamide, vitamin B12, thiamine and p- 
aminobenzoic acid  
- Self-maintenance of the 
anaerobic conditions  




- No peristaltic 
movement 
simulation  
- No host simulation 
TIM-2 (Minekus, 2015;  
Minekus et al., 1999;  
Smeets-Peeters et al., 
1999) 
GI Simulated Section: Proximal 
colon 
Inoculum: Human faecal 
samples; 11% microbiota (w/w) 
Gas Mixture: N2 
Temperature: 37 ◦C 
Stirring: Contraction of the 
flexible walls by water pressure 
pH: 5.8 
Working Volume: 200 mL 
Feed flow rate (medium): 4 mL/ 
h 
Chyme removal flow rate: 2 mL/ 
h 
Dialysis flow rate: 6 mL/min 
Retention Time: 80 h 
12 h microbial adaptation 
2–4 h starvation period 
Running Time: 3 d 
Pectin, xylan, arabinogalactan, amylopectin, 
starch, tween 80, bactopeptone, casein, hemin, 
cystein, menadione, D-biotin, vitamin B12, 
pantothenate, nicotinamide, p-aminobenzoic acid, 
thiamine, NaCl, K2HPO4, CaCl2, MgSO4, FeSO4 and 
bile salts  
- Peristaltic movements 
changed the water 
pressure on the flexible 
walls  
- Dialysis system  
- Parallel control and 
treatment  
- No host simulation 
Three-Stage Colonic Model 
System 
(Gibson et al., 1988;  
Macfarlane et al., 1998) 
GI Simulated Section: Ascending 
(V1), transverse (V2) and 
descending (V3) colon 
Inoculum: Human faecal samples 
Gas Mixture: O2-free N2 
Temperature: 37 ◦C 
Stirring: magnetically stirred 
pH: V1 = 6.0; V2 = 6.5; V3 = 7.0 
Working Volume: V1 = 220 mL; 
V2 = 320 mL; V3 = 320 mL 
Dilution rates: V1 = 0.14 h− 1 
Starch, pectin, guar gum, mucin (porcine gastric 
type III), xylan, arabinogalactan, inulin, casein, 
peptone water, tryptone, bile salts, yeast extract, 
FeSO4, NaCl, KCl, KH2PO4, MgSO4, CaCl2, 
NaHCO3, cysteine, hemin and tween 80  
- Simulates proximal, 
transversal and distal 
colon  
- Allows sampling at 
different zones of the 
colon  




- Risk of 
contamination  
- No host cells 
(continued on next page) 
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vessel, while the other is the control. Specific parameters including pH, 
temperature and gas injection are controlled by a computer software 
(McDonald et al., 2013, 2015). Each vessel is operated at a feed rate of 
400 mL/day (100 mL of inocula in 300 mL of culture media) to mimic 24 
h transit time. A 36-day stabilization period is needed to reach 
steady-state, i.e. without experimental manipulation. Cultures are gently 
mixed and flushed with N2, and pH is set at 6.9–7.0. Fermentation runs 
for 48 days’ post-inoculation. Once fermentation starts, media is 
continuously fed to the vessels, while the excess volume is transferred to 
the waste containers. The pH is regulated by automatic addition of acid 
or alkali solutions, and the temperature is controlled by a steel water 
jacket. Stirrers, at identical speed, maintain homogeneous conditions 
inside the vessels (McDonald et al., 2013, 2015). The TVSC is an 
adequate model to conduct perturbation studies. 
The TVSC has been applied to investigate the significance and 
efficacy of functional food ingredients, providing important information 
on their bioactivity, stability, bioaccessibility and bioavailability. For 
example, the stability and biological activity of wild blueberry poly-
phenols during GI digestion have been studied (Correa-Betanzo et al., 
2014). The TVSC has been also applied to evaluate food safety. The 
potential hazardous effects of the ingested food additive titanium di-
oxide nanoparticles, which are used as an additive (E171 or INS171) in 
e.g. gums, candies and puddings, have been evaluated within the TVSC 
(Dudefoi, Moniz, Allen-Vercoe, Ropers, & Walker, 2017). 
3.2.2. MiniBioReactor arrays 
The MiniBioReactor Arrays (MBRAs) is a simple continuous-flow 
system, which works at small volumes and simulates the distal colon. 
It was developed to evaluate microbial community dynamics (Auchtung, 
Robinson, & Britton, 2015). The MBRAs was designed by a computer 
Table 1 (continued ) 
Gut Model Operational Conditions Growth Media Advantages Disadvantages 
(Retention Time = 7 h); V2 = 0.10 
h− 1 (Retention Time = 10 h); V3 
= 0.10 h− 1 (Retention Time = 10 
h) 
Running Time: 16 d 
SHIME (Molly et al, 1993, 
1994; Van de Wiele et al., 
2015) 
GI Simulated Section: Stomach 
(V1), small intestine (V2), 
ascending (V3), transverse (V4) 
and descending (V5) colon 
Inoculum: Human faecal 
samples; 20% faecal suspension 
Gas Mixture: O2-free N2 or 90/ 
10% N2/CO2 
Temperature: 37 ◦C 
Stirring: 150 rpm 
pH: V3 = 5.6–5.9; V4 = 6.15–6.4; 
V5 = 6.6–6.9 
Working Volume: V3 = 500 mL; 
V4 = 800 mL; V5 = 600 mL 
Retention Time: V3 = 20 h; V4 =
32 h; V5 = 24 h 
Feed Flow Rate = 25 mL/h 
Four stages: stabilization (2 
weeks); basal (2 weeks); treatment 
(2–4 weeks); washout (2 weeks) 
Running Time: typically, 30 d per 
cycle 
Arabinogalctan, pectin, xylan, dextrins, starch, 
glucose, yeast extract, proteose-peptone, mucin, 
cysteine, NaHCO3, NaCl, K2HPO4, KH2PO4, CaCl2, 
MgSO4, hemin, tween 80, menadione, biotin, 
pantothenate, nicotinamide, vitamin B12, thiamin 
and p-aminobenzoic acid  
- Integrates the entire GI 
tract  
- Allows sampling at 
different regions of the GI 
tract  
- Maintains microbiome 
stability over a long 
timeframe  
- Differentiation between 
mucosal and luminal 
microbiome in M-SHIME 
setup  
- No host simulation 
EnteroMix (Mäkivuokko 
et al., 2006; Mäkivuokko, 
Nurmi, Nurminen, 
Stowell, & Rautonen, 
2005) 
GI Simulated Section: Ascending 
(V1), Transverse (V2) and 
Descending Colon (V3), Sigmoid- 
Colon (V4) 
Inoculum: Human faecal samples 
Gas Mixture: O2-free N2 
Temperature: 37 ◦C 
pH: V1 = 5.5; V2 = 6.0; V3 = 6.5; 
V4 = 7.0 
Working Volume: V1 = 3 mL; V2 
= 5 mL; V3 = 7 mL; V4 = 9 mL 
Running Time: 48 h of 
experience 
Starch, pectin, guar gum, mucin (porcine gastric 
type III), xylan, arabinogalactan, inulin, casein, 
peptone water, tryptone, bile salts, yeast extract, 
FeSO4, NaCl, KCl, KH2PO4, MgSO4, CaCl2, 
NaHCO3, cysteine, hemin and tween 80  
- Ability to run four parallel 
experiments using the 
same faecal sample as 
inoculum  
- Short-term 
experiments can be 
performed  




- No host cells 
SIMGI (Barroso et al., 
2015a, 2015b) 
GI Simulated Section: Stomach, 
Small Intestine (SI), Large 
Intestine: Ascending (AC), 
Transverse (TC) and Descending 
Colon (DC) 
Inoculum: Human faecal samples 
Gas Mixture: N2 
Temperature: 37 ◦C 
Stirring: 150 rpm 
pH: AC = 5.6 ± 0.2; TC = 6.3 ±
0.2; DC = 6.8 ± 0.2 
Working Volume: AC = 250 mL; 
TC = 400 mL; DC = 300 mL 
RT: 76 h 
Feed Flow Rate = 5 mL/min 
Stabilization period: 14 days 
Arabinogalactan, pectin from apple, xylan, potato 
starch, glucose, yeast extract, peptone, mucin and 
L-cysteine. 
The media for the small intestine is supplemented 
with pancreatic juice, NaHCO3, oxgall (dehydrate 
fresh bile) and porcine pancreatine  
- Digestion is simulated  
- Peristaltic movements are 
mimicked  
- Long period of culture  
- No host-interactions  
- Risk of 
contamination due to 
daily operation  
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assisted design software and manufactured by stereolithography with 
DSM Somos® Watershed XC 11122 (Robinson, Auchtung, Collins, & 
Britton, 2014). Each MBRA consists of six reactors with an internal 
volume of 25 mL and a working volume of 15 mL. The system operates 
inside a heated anaerobic chamber (37 ◦C), under 5% CO2 – 5% H2 - 90% 
N2 atmosphere. Prior to use, MBRAs and media are sterilized by auto-
claving. Then, the system is equilibrated for 72 h to reach an anaerobic 
environment. Typically, media is fed at a continuous-flow of 1.875 
mL/h, controlled by two 24-channel peristaltic pumps. The reactor 
contents are continuously stirred during the experiments. Due to their 
small size and simplistic design, it is possible to run up to 48 reactors 
simultaneously in a single anaerobic chamber, assessing multiple envi-
ronmental disturbances on the microbiota. The MBRAs have the 
advantage of the short time required to reach the steady state, while the 
low volume used in the system reduces running costs. 
The MBRAs were used to evaluate the effects of antibiotic clinda-
mycin and polyphenol extracts from pomegranate and blueberries on 
faecal microbial communities’ modulation. Microbiota modulated with 
polyphenols showed decreased colonization resistance against Clos-
tridioides difficile but could neutralize cytotoxicity, showing its potential 
as a non-antibiotic agent for the alleviation of C. difficile infection 
(Spinler et al., 2017). 
3.2.3. Environment control system for intestinal microbiota 
The Environment Control System for Intestinal Microbiota (ECSIM) 
is a modular system consisting of three reactors that can be used in 
several configurations to mimic different zones and functions of the 
human colon. For example, P-ECSIM simulates nutritional and physi-
cochemical relevant conditions of the gut microbiota in the proximal 
zone, and 3S-ECSIM simulates the proximal, transverse and distal colon 
zones (Feria-Gervasio, Denis, Alric, & Brugère, 2011). The ECSIM differs 
from other systems, since the anaerobic atmosphere is guaranteed 
through the gases released from the microbiota metabolism and no N2 or 
any other gas/gases mix are flushed (Feria-Gervasio et al., 2011). 
The composition of the culture medium used in the P-ECSIM mimics 
the terminal ileal chyme of an individual consuming a common western 
diet, as applied in other models (Macfarlane, Macfarlane, & Gibson, 
1998; Molly, Woestyne, & Verstraete, 1993). Each bioreactor has its own 
controlling terminal connected to a computer and four peristaltic pumps 
that feed nutrients, test solutions, and neutralizing solutions (Brugere, 
Feria-Gervasio, Popse, Tottey, & Alric, 2011). It consists of a 2 L stirred 
tank run with a fixed 1 L working volume, which is continuously 
adjusted (Brugere et al., 2011). A water jacket ensures bioreactors’ 
temperature (37 ◦C). Experiments are run at 400 rpm and pH is main-
tained at 5.75 by the automatic addition of 2 M NaOH. Two different 
retention times are typically used, namely 12.5 h and 25 h, simulating 
physiological or slow transit time (48 h or 96 h, respectively). 
The P-ESCIM has been used to unveil the link between colonic transit 
time and gut microbiota composition and metabolism (Tottey et al., 
2017). It provides additional insight towards the design of functional 
food solutions counter-acting modifications seen in the gut microbiota of 
the elderly, as well as patients with slow transit time. 
3.2.4. TNO gastro-intestinal model 
The TNO Gastro-Intestinal Model (TIM) is a system with different 
variations (TIM-1, TIM-2, tinyTIM, TIM-age). The proximal colon is 
simulated by the TIM-2, which consists of four glass compartments 
holding flexible membranes. When the membranes are compressed by 
water (set at 37 ◦C for humans, 39 ◦C for pigs, 41 ◦C for birds, etc.), the 
luminal content is mixed and moved through the system by a peristaltic 
wave (Minekus, 2015). The mixing allows working with high density 
microbiota, viscous “meals” and insoluble components. The system is 
equipped with a dialysis system which allows water absorption and 
regulation of the metabolites concentration, such as the SCFA that are 
taken up by the epithelial cells, avoiding microorganism inhibition or 
death, and keeping physiological concentrations (Minekus et al., 1999). 
The TIM-2 has been inoculated with pooled or individual faecal 
samples from healthy human volunteers or patients with GI disorders 
and obesity (Martinez et al., 2013). Pig’s (Martinez et al., 2013) and 
dog’s microbiota (Smeets-Peeters, Minekus, Havenaar, Schaafsma, & 
Verstegen, 1999) have also been tested. An adaptation period between 
12 h and 16 h is applied to the microbiota before the experiment starts, 
which normally lasts for 72 h. After this adaptation stage, a 2–4 h 
starvation period is applied to allow fermentation of all available car-
bohydrates prior to feed the tested substrate. Anaerobic conditions are 
kept by flushing with N2. In the first TIM-2 setup, feeding flow rate was 
set at 4 mL/h, chyme was removed at 2 mL/h, and the dialysis fluid flow 
was set at 6 mL/min. Samples were taken from lumen and dialysate to 
assess microbial metabolites production and to study changes in 
microbiota composition (Minekus et al., 1999). 
The TIM-2 takes advantage of peristalsis and nutrient absorption, 
which are key differentiating factors to provide a more realistic simu-
lated environment for the study of gut microbiota dynamics. Hence, this 
in vitro system is a landmark in the field. It has been widely used to assess 
fermentation patterns and the effects of prebiotic and probiotic sup-
plementation in the microbial composition (Kortman et al., 2016; 
Kovatcheva-Datchary et al., 2009; Minekus et al., 1999; Van Nuenen, 
Meyer, & Venema, 2003). Recently, new prebiotics obtained from food 
wastes, such as mango peel (Sáyago-Ayerdi, Zamora-Gasga, & Venema, 
2019) and mixtures of pectin-derived oligosaccharides from lemon peel 
(Miguez, Vila, Venema, Parajo, & Alonso, 2020) have been tested with 
gut microbiota from elderly donors. TIM-2 model has been also used to 
study the effect of food plant sterols enrichment dose on gut microbial 
profile, cholesterol metabolites and SCFA production of lean and obese 
populations (Cuevas-Tena, Alegria, Lagarda, & Venema, 2019). 
The Artificial Colon (ARCOL) is another example of a bioreactor 
system that simulates the colon. It was firstly used when coupled to the 
TIM-1 model and it is a one-stage, semi-continuous fermentation system. 
Several probes control the essential parameters, such as pH 6.0 and 
temperature at 37 ◦C, that are identical to the parameters observed in 
the human large intestine. Passive absorption is simulated using hollow 
fibre membranes (cut-off 30,000 Da). This dialysis step keeps electrolyte 
and metabolite balance, as well as the operating volume (450 mL). Ileal 
effluents, usually from TIM-1, are transferred to the ARCOL bioreactor in 
presence of a metabolically active human microbiota. Microbiota is 
maintained in anaerobic conditions only by the activity of intestinal 
microbiota (Blanquet-Diot et al., 2012). The ARCOL model has been 
applied to study the antagonistic effect of probiotic strain Saccharomyces 
cerevisiae against enterohemorrhagic E. coli O157:H7 and to understand 
some mechanisms of its pathogenesis (Cordonnier, 2015). 
Recently, the ARCOL was upgraded to the M-ARCOL, which includes 
mucin beads that represent the colon mucus microenvironment. Mucin 
beads are produced by dropping porcine stomach type II mucin/sodium 
alginate solution into 0.2 M CaCl2 solution, under agitation. The beads 
are inserted in an airtight glass compartment, where the microbial 
community circulates. Mucin beads accounted for a total surface area of 
556 cm2 for each fermentation, reproducing the mucus-associated 
microbiota. After the experiments, mucin/alginate beads are washed 
with phosphate buffered saline (PBS) and stored at − 80 ◦C for further 
analyses (Deschamps et al., 2020). 
3.2.5. Polyfermentor intestinal model 
The Polyfermentor Intestinal Model (PolyFermS) system mimics the 
proximal colon zone. It overcomes biological reproducibility problems 
associated to gut microbiota modulation, since it allows the study of 
multiple effects of different treatments, such as environmental param-
eters, dietary compounds and drugs on microbiota (Poeker et al., 2018). 
The PolyFermS uses immobilized faecal inoculum allowing continuous 
and prolonged culture of the microbiome. Fresh faecal microbiota is 
trapped in gel beads, growing to high concentration. Effluents of this 
first-stage inoculum reactor are then used to continuously feed several 
second-stage control and experimental reactors operating in parallel. 
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Fermented effluents are equally distributed on the reactors (working 
volumes of 300 mL), for a mean retention time of 7.5 h (Berner et al., 
2013). The PolyFermS significantly improved bacterial density, biodi-
versity and long-term microbiota stability, which is reflected on opera-
tion times up to 80 days (Dostal, Fehlbaum, Chassard, Zimmermann, & 
Lacroix, 2013; Fehlbaum et al., 2015). The microbiota immobilization 
prevents washout of less competitive bacteria and ensures the repeated 
exposure of a single microbiota, for example, to different dietary fibres 
(Berner et al., 2013). The PolyFermS has been used to evaluate the po-
tential of different type of bacteria and dietary fibres as probiotic or 
prebiotic, e.g. β-glucans, α-galactooligosaccharides (α-GOS) and xyloo-
ligosaccharides (XOS) (Fehlbaum et al., 2019; Poeker et al., 2018). 
Changes observed in the SCFA profile were correlated with changes in 
the abundance of specific bacteria upon prebiotic supplementation. 
These results highlight the importance of understanding the 
inter-individual response to a prebiotic treatment. 
3.3. Multi-stage continuous culture models 
Multi-stage continuous models represent a more reliable approach to 
replicate the environment along the human colon. The proximal 
(ascending) colon is typically an acidic and nutrient-rich environment 
resulting from bacterial fermentation processes. It becomes progres-
sively more alkaline and nutrients are depleted towards the transverse 
(middle) colon and reaches near pH-neutral in the distal (descending) 
colon. Therefore, these multi-stage systems usually use three fermen-
tation vessels connected sequentially to mimic specific environment 
physicochemical conditions over the three major anatomic colon regions 
(Williams et al., 2015). The majority of these in vitro gut models are 
based on the three-stage colonic model design developed by Gibson, 
Cummings, and Macfarlane (1988). Influx of gastric juice, pancreatic 
juice and bile salts, peristaltic motility, absorption capacity and high 
shear forces (Williams et al., 2015) allow to model the gut dynamic 
environment. Parameters such as temperature, flow rate, pH, retention 
time, and anaerobiosis of the medium are strictly controlled to mimic 
the in vivo human colon, which contributes to the establishment of 
steady-state conditions for microbial composition and metabolic activity 
(Bajury, Nashri, King Jie Hung, & Sarbini, 2018). 
The most relevant examples of multi-stage continuous culture 
models are briefly described in the next sub-sections. 
3.3.1. Three-stage colonic model system 
Macfarlane et al. (1998) validated one of the first multi-stage 
continuous culture models - proposed by Gibson et al. (1988) in their 
80’s work - to simulate ascending, transverse and descending colon 
environmental and nutritional conditions. This in vitro model comprises 
three fermentation vessels (V1, V2 and V3) connected sequentially to 
simulate the microbial activities in the ascending, transverse, and 
descending colon. Each of these fermentation vessels takes into account 
the following characteristics: 1) the ascending colon is a nutrient-rich 
environment comprising microbial growth at low pH; and 2) the other 
two colon subparts are nutrient limited and present slow microbial 
growth at an increasing pH whereas oxygen-free conditions, pH, transit 
time and stirring conditions are controlled (Gibson et al., 1988; Mac-
farlane, Cummings, Macfarlane, & Gibson, 1989). 
A typical experimental setup of this model consists in the inoculation 
of each vessel with human faecal slurry. Microbiota is then grown 
overnight, in batch, to increase initial biomass. Operating volumes of 
220 mL, 320 mL and 320 mL, are used for V1, V2 and V3 (vessels), 
respectively. Individual dilution rates of 0.14 h− 1, 0.10 h− 1, and 0.10 
h− 1 are used, yielding a total retention time of ~27 h (Macfarlane et al., 
1998). The vessels are held at 37 ◦C and at pH 6.0, 6.5 and 7.0, 
respectively. Medium, continuously flushed with N2, is feed by a peri-
staltic pump up to V1, at a rate correspondent to the desired retention 
time, often 48 h. This represents a typical transit time through the 
human colon and overcomes washout of key bacterial species ensuring a 
stable microbial community (Macfarlane et al., 1998). Overflow from V1 
is then transferred to V2 and from V2 to V3 via gravitational flow. 
Overflow from V3 is collected as waste. The system is run until microbial 
communities reach steady state, which typically takes 8 turnovers, or 16 
days. Steady state is confirmed after obtaining consistent SCFA profiles, 
during three consecutive days (Macfarlane et al., 1998). 
The representativeness of the true in vivo conditions reached by this 
model has been validated against intestinal contents from sudden death 
victims. Both bacterial and chemical SCFA profiles from the in vitro 
model and human intestinal samples were shown to be similar (Mac-
farlane et al., 1998). Although the system does not incorporate host 
factors such as intestinal immunology, secretions, or absorption – hence 
not offering a fully accurate human gut representation of chemical and 
physiological conditions – it does provide an inexpensive and reliable 
tool for modelling colon microbial ecology and activity. Consequently, it 
has become a standard reference in the field and the basis to all 
multi-stage continuous culture models. Recently, this model was used to 
validate health benefits from a commercial wheat dextrin soluble fibre, 
which have shown significant butyrogenic effect on gut microbiota 
ecology (Hobden et al., 2013). It has been also used to evaluate the 
prebiotic activity of orange juice supplemented with a GOS mixture with 
and without Bimuno (B-GOS). The combination of orange juice and 
B-GOS resulted in an increase of Roseburia subcluster and consequently, 
butyrate production increased, which have been associated with many 
benefits to host health (Costabile et al., 2015). 
3.3.2. Simulator of the human intestinal microbial ecosystem 
The Simulator of the Human Intestinal Microbial Ecosystem (SHIME) 
is one of the few gut models that mimics the entire GI tract. It consists of 
five double-jacketed glass vessels that are connected through peristaltic 
pumps, simulating stomach, small intestine and three colon regions – 
ascending (pH = 5.6–5.9), transverse (pH = 6.15–6.4) and descending 
(pH = 6.6–6.9) (Molly et al., 1993). The first two reactors mimic the 
enzymatic and physicochemical environment by controlling pH, resi-
dence time, and culture medium volume, including enzymes and bile 
salts (Molly, Woestyne, Smet, & Verstraete, 1994). These two reactors 
have a fill-and-draw system with a dialysis filter used to simulate 
absorptive processes occurring in the stomach and small intestine 
(Vermeiren et al., 2011). Upon digestion on the gastric and intestinal 
compartments, the slurry is pumped into the ascending colon vessel, 
where fermentation is initiated. The last three-stage reactors, which 
simulate the large intestine, are continuously stirred vessels inoculated 
with fresh faecal samples, corresponding to the in vivo conditions in 
terms of metabolic activity and community composition based on the 
aforementioned Gibson et al. (1988) model. The vessels are held at 37 ◦C 
and the entire SHIME system is kept under anaerobic conditions by daily 
flushing the respective compartments headspace with N2 or a 90/10% 
N2/CO2 gas mixture (Van de Wiele, Van den Abbeele, Ossieur, Pos-
semiers, & Marzorati, 2015). The digestive slurry is mixed with mag-
netic stir bars. Since the stirring is magnetic, no peristalsis mimicking 
mechanisms are available in the SHIME, which represents a potential 
limitation of this specific approach. Three times per day, 140 mL of 
nutritional medium and 60 mL of pancreatic juice are added to the 
stomach and small intestine compartments, respectively (Molly et al., 
1993). The operating volumes and respective residence times for each 
colon vessels are: ascending 500 mL and 20 h; transverse 800 mL and 32 
h; and descending 600 mL and 24 h (Williams et al., 2015). 
A typical SHIME experiment consists of four stages: 1) a stabilization 
period (2 weeks) to allow microbial community adaptation to the 
environmental conditions of each colon zone; 2) a basal period (2 
weeks), operating under nominal conditions to measure baseline pa-
rameters; 3) a treatment period (2–4 weeks) to test the effect of a specific 
treatment on the GI microbial community; and 4) a washout period (2 
weeks) to determine how long the changes induced by the tested sub-
stance remain after finishing the treatment (Van de Wiele et al., 2015). 
This approach has been applied to investigate probiotics and prebiotics 
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activity and stability along the GI tract; microbial conversion of bioac-
tive food components; metabolism of pharmaceutical compounds; effi-
cacy of colonic targeted delivery systems; and conversion and biological 
(in)activation of food and/or ingested environmental contaminants 
(Van de Wiele et al., 2015). The SHIME model has been used to study the 
effects of fructooligosaccharides (FOS) on the microbiota fermentation 
pattern (Sivieri et al., 2014), highlighting not only its bifidogenic effect 
but also the increase of SCFA production. Recently, the SHIME model 
was used to compare the bifidogenic effects of goat and cow milk-based 
infant formulas of human breast milk on 3-month-old infants (Gallier, 
Van den Abbeele, & Prosser, 2020). Results showed that the naturally 
present oligosaccharides stimulate gut microbial activity and commu-
nity composition in a way comparable to human milk, despite the 
absence of specific supplementation with human milk oligosaccharides 
(HMOs). 
To achieve a representative mucosal environment, like that observed 
in the human colon, a mucous compartment was incorporated in the 
SHIME, containing hundreds of mucin-covered microcosms (M-SHIME) 
(Van den Abbeele et al., 2012). These microcosms are cylindrical 
high-density polyethylene ring shaped carriers (length: 7 mm; diameter: 
9 mm; total surface area: 800 m2 m− 3). The microcosms are coated by 
submersion into mucin agar. The M-SHIME has been used under the 
same operation parameters as the ones used in the SHIME, in experi-
ments run up to 28 days. Results shown that probiotic bacteria - 
L. rhamnosus GG (LGG) and L. mucosae - selectively colonize the micro-
cosms (Van den Abbeele et al., 2012). The M-SHIME was used also to 
study the benefits associated with the intake of a commercial probiotic 
formulation (MegaDuo™) containing Bacillus coagulans SC208 and Ba-
cillus subtilis HU58 (Marzorati et al., 2020). This approach is relevant for 
long-term studies comprising microbial colonization of the mucus layer, 
being particularly useful for demonstrating prebiotic, probiotic, and 
antibiotic effects. 
3.3.3. EnteroMix 
The EnteroMix model is a modified, semi-continuous culture colon 
simulator with four parallel units (Mäkivuokko, Saarinen, Ouwehand, & 
Rautonen, 2006). Each unit comprises four glass vessels representing the 
ascending, transverse, descending, and sigmoid-colon/rectum, working 
with small volumes (3, 5, 7, and 9 mL, respectively) and controlled pH 
(5.0, 6.0, 6.5, and 7.0, respectively). The simulator unit is kept in a 
thermostatic room at 37 ◦C and anoxic N2 is gassed in all vessels to keep 
anaerobic conditions. Three hours after inoculation of the faecal inoc-
ulum the test substance is pumped to the first vessel - 3 mL of fresh 
medium with (three test channels) or without (one control channel). The 
content is fermented for 3 h before being transferred to the second vessel 
with simultaneous addition of 3 mL fresh medium into the first vessel. 
The same process is repeated for the third and fourth vessel, the system 
setup is completed within 15 h post-inoculation. The fermentation lasts 
for 48 h with substrate feeding every 3 h, so that the microbiota can 
adapt to the substrate, and bacteria profile and its metabolites can be 
analysed (Mäkivuokko et al., 2006). 
The EnteroMix model was designed specifically to study the carbo-
hydrate fermentation by colonic microbiota (Mäkeläinen et al., 2010; 
Mäkeläinen, Mäkivuokko, Salminen, Rautonen, & Ouwehand, 2007; 
Mäkivuokko et al., 2006). An advantage of this model is the ability to 
run four parallel experiments using the same faecal inoculum. However, 
only short-term experiments can be performed due to the small working 
volumes and semi-continuous nature of the system, thus reducing cor-
relation with in vivo studies (Williams et al., 2015). Among the 
food-related applications of the EnteroMix, the comparison between 
prebiotic effect of FOS and XOS is of the utmost relevance (Mäkeläinen 
et al., 2010). The EnteroMix has shown that B. lactis and XOS mixture 
form a successful, symbiotic combination. More recently, the EnteroMix 
was used to demonstrate the positive effects of HMOs (Salli et al., 2019). 
3.3.4. Computer-controlled dynamic simulator of the gastro-intestinal tract 
The computer-controlled dynamic SIMulator of the GastroIntestinal 
tract (SIMGI) is a fully automated GI multi-chamber simulator. It com-
prises five units, simulating the stomach, small intestine and three stages 
of the large intestine (ascending, transverse and descending), which are 
interconnected by pipes and peristaltic valve pumps that transfer the 
content between the successive units (Barroso, Cueva, Peláez, Martí-
nez-Cuesta, & Requena, 2015a, 2015b). The stomach unit is comprised 
of two transparent and rigid methacrylate plastic modules covering a 
reservoir of flexible silicone walls where the gastric content is mixed by 
peristaltic movements. The gastric peristalsis is achieved by pumping 
thermostatized water in the jacket between the plastic modules and the 
flexible reservoir, which keeps gastric temperature content at 37 ◦C 
(Barroso, Cueva, Peláez, Martínez-Cuesta, & Requena, 2015b). The 
stomach compartment has different ports for input of experimental food 
components, gastric juice, and HCl. The meal received by the stomach 
compartment is mixed with gastric electrolytes and enzymes. The 
decrease of pH is regulated by computer-controlled addition of 0.5 M 
HCl to follow the curve resulting from a linear fit of data representing 
experimental in vivo conditions (Barroso et al., 2015b). 
The small intestine consists of a double jacket glass reactor vessel, 
magnetic stirred at 150 rpm that receives the gastric content which is 
mixed with pancreatic juice and bile. The intestinal content is digested 
during 2 h at 37 ◦C and kept at pH 6.8 (Barroso et al., 2015b). 
Lastly, large intestine stages are simulated in three double jacket 
glass reactors and the colon content is kept at 37 ◦C by pumping water 
into the space between the glass jackets. The glass reactors are inocu-
lated with faecal samples, filled and pre-conditioned with the nutritive 
medium that will fed the system (i.e. 250, 400 and 300 mL for the 
ascending, transverse and descending colon compartments, respec-
tively). The pH is controlled by addition of 0.5 M NaOH and/or 0.5 M 
HCl to maintain pH values at 5.6 ± 0.2 in the ascending, 6.3 ± 0.2 in the 
transverse and 6.8 ± 0.2 in the descending compartments. The colonic 
volume units and the transit of colonic content between compartments, 
that occurs three times a day at a flow rate of 5 mL/min, are intended to 
give an overall residence time of 76 h. The colon microbiota stabilization 
process in the three colonic units is usually reached after 14 days under 
the aforementioned conditions (Barroso et al., 2015a, 2015b). 
The SIMGI is designed to operates with five units simulating the 
dynamics of whole GI process. In addition, the SIMGI software allows 
the operation of the stomach and the small intestine modules in a 
continuous mode to study food digestion together with the microbial 
community development in the colonic vessels. The system is flexible 
and can be adapted according to the envisaged experimental approach 
(Barroso et al., 2015a). SIMGI has been extensively used in the last few 
years in multiple food-related applications to assess digestibility and 
prebiotic effect, e.g. citrus pectin (Ferreira-Lazarte, Moreno, Cueva, 
Gil-Sánchez, & Villamiel, 2019) and chia seed mucilage (Tamargo, 
Cueva, Laguna, Moreno-Arribas, & Muñoz, 2018). Besides serving as a 
platform for functional food evaluation, SIMGI-related research has 
been revealing its use as an in vitro tool to evaluate silver nanoparticles 
digestion (Cueva et al., 2019), prior to human studies, and therefore, 
minimizing animal testing. 
3.4. Microbiome-host interaction models 
Human colon microbiome plays a major role in the health-disease pro-
cess as a result of interactions between microbiome, intestinal epithelium 
and immune system (Proctor et al., 2019). It has been a challenge to study 
microbiome-host interaction since: 1) it is not possible to reach microbiota 
specific sites at different digestion times in human trials, which unable 
control of all variables required for elucidating mechanistic and testing hy-
pothesis (Kostic, Howitt, & Garrett, 2013); 2) despite animal models ad-
vances (e.g. using mice microbiome), they are still not reliable to represent 
the human physiology and microbiome due to differences on biological or-
ganization and structure (Kostic et al., 2013); and 3) human and animal 
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studies involve major ethical issues, are time consuming and costly (Wilmes, 
Calatayud, & Van de Wiele, 2018). On the other hand, in vitro models have 
significantly evolved in the last decade, from simple static to complex dy-
namic systems (Berni, Chitchumroonchokchai, Canniatti-Brazaca, De 
Moura, & Failla, 2015; Kortman et al., 2016; Silva et al., 2018). Reliable and 
convenient microbiome-host simulators are critical for research advances in 
this field. However, at present, no available system offers a holistic approach 
comprising peristalsis simulation-microbiome-enterocytes or micro 
biome-epithelium-immune system. 
The main challenge to be addressed by microbiome-host models is 
how to emulate all the interactions features on a single model, including 
physiological biochemistry (e.g. digestive enzymes and anaerobic/aer-
obic microenvironment), biological organization (e.g. villi, microbial 
adhesion and epithelial barrier) and physical forces (e.g. peristalsis and 
shear stress) (May et al., 2017). Each feature requires the establishment 
of detailed and precise models that need to be integrated in an overall 
setup. For example, it is necessary to confirm the cell monolayers 
integrity and barrier formation, usually measured by transepithelial 
electrical resistance (TEER) and microscopy methods that assess tight 
junctions and epithelium morphology (Shah et al., 2016). Also, it is 
important to establish how long cellular cultures survive with bacteria 
while running the system (May et al., 2017) and to test whether the 
intestinal barrier permeability is at physiologic level (Kim & Ingber, 
2013). Finally, it is of utmost importance to choose relevant biomarkers 
to assess if the involved biochemistry is as close as possible to human 
physiology (Eain et al., 2017). 
At the moment, four microfluidics-based microbiome-host interface 
models have been described: the pioneer Gut-on-a-Chip (Kim, Huh, 
Hamilton, & Ingber, 2012); the HuMiX (Shah, Fritz, Estes, Zenhausern, 
& Wilmes, 2014); the HMI™ module for the SHIME (Marzorati et al., 
2014); and the MOTiF (multi-organ-tissue-flow) intestine-on-chip 
(Maurer et al., 2019). Their structures, operational parameters, 
cellular and microbial cultures are presented in Table 2 and discussed in 
the next sub-sections. 
3.4.1. Microfluidic-based microbiome-host models: design, operational 
parameters and co-cultures 
Microfluidics and bioengineering have been combined to mimic the 
human intestinal functions in a small-scale fluid flow system, similar to a 
chip. Current models evolved from static co-cultures cultivated on 
Transwell® (Bein et al., 2018) to co-cultures in continuous flow similar 
to in vivo physiologic shear-stress and eventually, under mechanic forces 
(peristalsis) (Kim et al., 2012). These models need to define the intes-
tinal part and/or health/disease state to be modelled since the intestinal 
epithelium morphology and microenvironment may be quite different 
on various intestinal sections (Donaldson, Lee, & Mazmanian, 2015) and 
under specific health/disease conditions (von Martels et al., 2017). 
Microbiome-host models need at least two compartments simulating 
microaerophilic intestinal lumen environment and aerobic conditions to 
human enterocytes, i.e. host’s colon epithelium, growth and differenti-
ation (May et al., 2017). It is also required a barrier where metabolites, 
biomarkers, oxygen, nutrients, and other compounds of interest can 
Table 2 
Overview of microbiome-host interaction models’ structure, operational parameters, cellular and microbial cultures.  
Gut-on-a-Chip (Kim et al., 2012, 
2015, 2016) 
Human cell types Enterocytes (Caco-2), capillary endothelial, lymphatic microvascular endothelial, immune system (monocytes, 
lymphocytes and granulocytes) 
Microbial cultures Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, Bifidobacterium breve, Bifidobacterium longum, 
Bifidobacterium infantis, Escherichia coli (GFP-EC and EIEC), Bifidobacterium adolescentis and Eubacterium hallii 
Media flowing in the 
system 
DMEM, 20% FBS, 1% antibiotics – for co-culture is used antibiotics free media, for anaerobic conditions is used anoxic 
media. Flow: 30 μL h− 1 
Device structure Upper and lower microchannels (1 mm width × 10 mm length × 0.15 mm height) confectioned in PDMS polymer, 
bilateral vacuum chambers (1.68 mm × 9.09 mm × 0.15 mm) 
Barrier and 
permeability 
30 μm thick PDMS membrane containing 10 μm diameter circular pores with 25 μm spacing; apparent permeability 
was ≈4 × 10− 8 cm s− 1 at 30 μL h− 1 flow and 4 times higher under strain (peristalsis) 
Peristalsis 0.02 dyne cm2 shear stress by flow, mechanical deformations (10% in cell strain, 0.15 Hz in frequency) by vacuum 
pumps (≈15 kPa of suction pressure) 
HuMiX (Shah et al., 2016) Human cell types Epithelial colorectal cells (Caco-2 and CCD-18Co) and immune cells (CD4+T) 
Microbiota Lactobacillus rhamnosus GG and Bacteroides caccae 
Media flowing in the 
system 
DMEM, 20% FBS, 1% antibiotics – for co-culture is used antibiotics free media, for anaerobic conditions is used anoxic 
media; Flow: 25 μL min− 1 
Device structure Three spiral channels (4 mm width × 200 mm length × 0.5 mm height; surface area ~8 cm2 each channel) 
confectioned in silicon rubber gasket (65 mm × 65 mm), covered by two sides of polycarbonate enclosure 
Barrier and 
permeability 
Polycarbonate membranes, 50 nm pore sizes among microbial and epithelial chambers, coated with mucin, and 1 μm 
pore size among epithelial and perfusion chambers, coated with collagen. Permeability from microbial microchamber 
to the perfusion microchamber was 5.41 × 10− 6 cm s− 1 
Peristalsis There is no peristalsis system beyond the shear stress caused by the flow 
HMI™ (Marzorati et al., 2016) Human cell types Epithelial colorectal cells (Caco-2) 
Microbiota Lactobacillus rhamnosus GG, Saccharomyces cerevisiae and complex microbial community from human fecal sample 
Media flowing in the 
system 
DMEM, 10% FBS, 1% NEAA, 2% antibiotics and fungizone; for experiment was used media free of antibiotics and 
fungizone in the lower compartment. Upper compartment was feed with ascendant colon stage of SHIME. Flow: 6.5 
mL min− 1 upper compartment, 2 mL min− 1 in the lower compartment 
Device structure Module connected to SHIME, two compartments (60 mm width × 100 mm length), area for culture was a glass cover 
~ 25 mm wide x 75 mm longa 
Barrier and 
permeability 
Polyamide membrane (0.2 μm pore size, 115 μm of thickness) with a mucus layer (mucin + agar, 200–250 μm of 
thickness), permeability ranging 2.4 × 10− 6 to 7.1 × 10− 9 cm s− 1 
Peristalsis 3 dyne cm2 shear stress by flow. There is no additional peristalsis system 
MOTiF intestine-on-chip ( 
Maurer et al., 2019) 
Human cell types Human umbilical cord vein endothelial cells (HUVECs), epithelial colorectal cells (Caco-2), peripheral blood 
mononuclear cells and primary macrophages (PBMCs) 
Microbiota Lactobacillus rhamnosus GG and Candida albicans 
Media flowing in the 
system 
The endothelial layer was cyclically perfused with a flow rate of 50 μl min− 1 while the luminal chamber was linearly 
perfused with 25 μl min− 1 
Device structure Upper and lower chambers with 700 and 400 μm height, respectively, feed by two microchannel. The available area 
for cell culture was 1.1 cm2. Constructed in polystyrol 
Barrier and 
permeability 
12 μm thin polyethylene terephthalate (PET) membrane (8 μm pore size). Endothelial and Caco-2 cells were cultured 
in the opposite sides of the same membrane. Permeability ≈5 μg mL− 1 of FITC dextran after 30 min perfusion 
Peristalsis 0.07 Pa of shear stress at endothelial side and 0.03 Pa at epithelial side. There is no additional peristalsis system  
a Approximation based on Marzorati et al., 2016, since specific details are not reported. 
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permeate (Wilmes et al., 2018). 
The Gut-on-a-Chip (Kim et al., 2012) and the HMI™ (Marzorati et al., 
2014) are both structured as two channels aligned on top of each other, 
while the HuMiX (Shah et al., 2016) have three channels aligned in 
spiral format. Regarding the MOTiF intestine-on-chip structure, 
epithelial cells are grown on one side of the membrane and bacteria on 
the top chamber, while endothelial cells are cultured on the opposite 
side of the membrane with immune cells in the bottom chamber making 
it a 4-stage system (Maurer et al., 2019). Although these devices seek to 
model the microbiome-host interaction, each structural design provides 
a different approach. The Gut-on-a-Chip has the narrower channel (0.15 
mm high x 1 mm wide) and therefore, the smaller culture area, followed 
by the MOTiF intestine-on-chip model (1.1 cm2 culture area) (Table 2). 
These narrow channels may be a limitation for applications including 
complex microbiome-host experiments. For example, many compounds 
firstly need to be metabolized by microbial species in a cross-feeding 
mode (Marzorati et al., 2014), and many prebiotics, like soluble fibres, 
increase faeces viscosity causing channel clogging (McRorie & 
McKeown, 2017). Moreover, localized bacteria overgrowth induced 
epithelial cells death within 48 h, despite being counterbalanced by 
continuous media flow and peristalsis-like motions (Kim et al., 2012). 
Eain et al. (2017) claimed that the Nutri-Humix system works for 
extended periods of time with bacteria and host cells co-cultures. 
However, only two probiotic strains, LGG and Bacteroides caccae in 
media supplemented with a soy prebiotic were used and co-cultured 
with human Caco-2 cells in the epithelial chamber for 24 h (Shah 
et al., 2016). On the other hand, the three membrane-separated channels 
of the HuMiX succeed to create a microbial-immune system interaction, 
when co-culturing anaerobic LGG, epithelial colorectal cells (Caco-2 and 
CCD-18Co) and immune CD4+T cells (Shah et al., 2016). Thus, the 
modular three channels design is particularly interesting, due to its 
flexibility and dynamics, for simulation of different health/disease 
conditions. 
The HMI™ model has a completely different approach - it was 
designed to work as an external module coupled to the SHIME. It in-
troduces one more step in the system: indirect assessment of the 
microbiome-host epithelium interaction. The HMI™ module provides 
the possibility to work in parallel with control samples, or with more 
than one treatment at same time (Marzorati et al., 2014). Furthermore, 
the HMI™ could be adapted to other models similar to the SHIME. This 
device presents superior surface area for cellular and bacteria cultures 
growth requiring higher media volumes; hence, it works at higher shear 
stress level compared to the Gut-on-a-Chip and the HuMiX models 
(Table 2). The great difference is that the top chamber is fed by complex 
microbiota from the SHIME. It has a membrane covered with artificial 
mucus layer, similar to the human intestinal mucus, where bacteria 
adhere and grow. Caco-2 cells are cultured on the lower chamber until 
monolayers are differentiated. This model does not have a basal side, i.e. 
the HMI™ only simulates the epithelium’s surface (Marzorati et al., 
2014). 
Caco-2 cells are largely used to simulate intestinal epithelium (Joc-
hems, Garssen, Van Keulen, Masereeuw, & Jeurink, 2018) in several 
models for studying nutrient absorption and metabolism (Berni et al., 
2015) and bacteria-host interactions (Barnett, Roy, Cookson, & 
McNabb, 2018), which is the case of the four microfluidic-based ap-
proaches presented previously (Table 2). However, there are two main 
limitations in culturing Caco-2 cells in human gut models despite their 
extended use in several scientific fields. Caco-2 are undifferentiated cells 
that spontaneously differentiate in small intestine phenotype (Jochems 
et al., 2018). Differentiation can be accelerated by continuous media 
flow, mechanical peristalsis-like deformation and shear stress from the 
Gut-on-a-Chip device – presenting villi, crypt and mucin-2 in shorter 
culture times (Kim & Ingber, 2013). However, there is no villi occurring 
at the colon section of the human intestine (May et al., 2017). It is worth 
pointing out that the gut microbiota is mainly located in the colon 
(Labarthe et al., 2019). Thereby, the colon microbiome-enterocytes-like 
Caco-2 cells crosstalk has to be analysed with caution when extrapo-
lating in vitro results to the context of human subjects. Additionally, the 
Caco-2 cell is a colon cancer-derived cell line; thus, these cells can 
behave differently from normal epithelial cells (May et al., 2017). For 
example, Caco-2 cells can overexpress peptide transporters or even ex-
press transporters that do not occur in the human intestine (Jochems 
et al., 2018). Thus, Caco-2 cells may not be the most suitable cell to be 
used on these models but, for the moment are still the most feasible. 
Regarding flow and peristalsis simulation in microfluidic devices, it 
is fundamental to recall that these physical forces inside human colon 
will drive not only the microbiota location (i.e. mainly in the descending 
colon due to faeces straightforward motility and increasing viscosity) 
but also their inner ecology, prevalence, biogeographic distribution, 
bacterial motility vs mucus adhesion, and microbiome-host interaction 
(Donaldson et al., 2015; Labarthe et al., 2019). Some of these forces have 
already been partially simulated (Table 2). For example, mechanical 
deformation was performed by vacuum pumps mimicking peristalsis 
motion (Kim et al., 2012). Media flow has been precisely controlled 
reaching shear stresses similar to the human intestine epithelium surface 
(Kim et al., 2012; Marzorati et al., 2014). The artificial mucus layer, 
placed in microfluidic devices, allowed selective adhesion of bacteria 
(Marzorati et al., 2014). However, some complex events and in-
teractions were not yet implemented, like bacteria chemotaxis that is 
dependent on mucosal morphology, faeces viscosity and differential 
carbon source along the gut. 
The probiotic effect of LGG has been tested in the Gut-on-a-Chip 
model (Kim et al., 2012). Main results shown that LGG co-cultured in 
the lumen of the intestinal epithelial channel increased the intestinal 
barrier function. In another study, the VSL#3® probiotic formulation (i. 
e. a mix of 8 strains of lactic acid–producing bacteria) suppressed villus 
blunting and loss of barrier function induced by pathogenic E. coli (Kim, 
Li, Collins, & Ingber, 2016). 
Controlling the peristalsis and flow of microfluidic devices has 
additional and important effects, such as cellular morphogenesis mod-
ulation (Shin, Hinojosa, Ingber, & Kim, 2019), and selective adhesion 
and growth regulation of the bacterial community (Kim et al., 2016). 
Moreover, when continuous flow media are applied to Caco-2 cells using 
the Gut-on-a-Chip device, they exhibit a robust 3D small intestine 
morphology presenting differentiated absorptive, goblet, enter-
oendocrine, and paneth cells localized in basal crypts (Kim & Ingber, 
2013). Also, high media flow increased Caco-2 cells height and polari-
zation and accelerated epithelial monolayers development usually from 
21 to 3 days, generating a specialized apical brush border, augmented 
barrier function, and mucus production (Kim & Ingber, 2013). It has 
been shown that the transepithelial Wnt antagonist Dickkopf-1 gradient 
and flow-induced Frizzled-9 receptor regulation mediate this morpho-
genesis (Shin et al., 2019). It is important to highlight that this 
morphology is typical from small intestine and cannot be applied for 
colonic microbiota-host studies. Therefore, it is essential to induce 
cellular culture differentiation to colon-like morphology to study colon 
microbiome-host interactions. 
4. In vitro models’ as a tool to predict host-microbiota response 
to prebiotics and probiotics 
The use of probiotics and prebiotics could be an affordable strategy 
for microbiota modulation, and it represents a promising option for 
human health promotion (Valdés et al., 2016). Probiotics are 
non-pathogenic bacteria or yeasts that have an impact on host health or 
physiology. The probiotics are known to be implicated in intestinal 
defence against pathogens, improving intestine epithelial layer and 
enhancing the immune response (Cordonnier et al., 2015). The main 
mechanism of action comprises epithelial cells stimulus and dendritic 
cells by toll-like receptors (TLRs) activation which produce cytokines 
(Rajput & Li, 2012). Probiotics immunomodulatory effects are ascribed 
to cytokines release, including interleukins (ILs), tumour necrosis factors 
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(TNFs), interferons (IFNs), transforming growth factor (TGF), and che-
mokines from immune cells, i.e. lymphocytes, granulocytes, macro-
phages, mast cells, epithelial cells, and dendritic cells (DCs), that control 
the innate and adaptive immune system (Azad et al., 2018). On the other 
hand, prebiotics such as inulin, FOS and GOS, which are mainly ob-
tained from plants by direct extraction, natural polysaccharides hydro-
lysis or enzymatic synthesis, have the capacity to increase probiotic 
population and/or activities in the human large intestine (de la Rosa 
et al., 2019; Nobre, Gonçalves, Teixeira, & Rodrigues, 2018). Several 
positive effects of prebiotics on numerous diseases are already well 
established, e.g. diabetes, Alzheimer’s disease, obesity, cancer, irritable 
bowel disease, osteoporosis, mood alterations, cardiovascular and im-
mune functions (Iramaia Angelica Neri-Numa, 2020; Nobre, Cerqueira, 
Rodrigues, Vicente, & Teixeira, 2015). However, due to the arrival of 
new prebiotic candidates, especially non-digestible oligosaccharides, it 
is fundamental to understand their main mechanisms of action (Gibson 
et al., 2017). 
In vitro models are an excellent approach to assess host-microbiota 
interaction with probiotics and prebiotics. However, most of the 
research studies report the use of less complex in vitro colon models (i.e. 
in vitro fermentation systems without immobilized human cells, such as 
TIM-2 model) compared to multipart, continuous in vitro host- 
microbiota models (e.g. the Gut-on-a-Chip and the HuMiX). Some ex-
amples of in vitro fermentation models and cell culture models, used 
independently, to study the effect of probiotics and prebiotics were re-
ported. For instance, an in vitro wheat aleurone fermentation (using a 
batch culture model) by faecal bacteria combined with probiotic strains 
of LGG and Bifidobacterium lactis Bb12 was evaluated to identify the 
effects of aleurone on HT-29 and LT97 human colon cell lines (Borowicki 
et al., 2010). In this study, the generated fermentation supernatants 
were applied to cell cultures. The cellular growth, apoptosis, and dif-
ferentiation, as well as the expression of genes involved in pathways of 
cell cycle regulation (p21), apoptosis (DR5), or both events (WNT2B) 
was investigated (Borowicki et al., 2010). It was observed a considerable 
increase in apoptosis and an up-regulation of genes involved in cell 
growth and apoptosis (i.e. p21 and WNT2B, respectively) when treated 
with all fermentation metabolites. In another study, a single bioreactor 
system was used to evaluate the survival, recovery, and dynamics of 
multi-strain probiotics composed of bifidobacteria and lactobacilli 
combined with mixed prebiotics (GOS, FOS, XOS or soluble starch) 
under GI tract changing environmental conditions (Adamberg et al., 
2014). The authors observed that Bifidobacterium breve 46, Lactobacillus 
plantarum F44, and Lactobacillus paracasei F8 were capable to grow 
synergistically in mixed culture and they were the most resistant strains 
under acid and bile exposure conditions. Other authors studied the effect 
of the daily administration of Kluyveromyces marxianus B0399 on the 
human intestinal microbiota composition and metabolic activity was 
investigated in a 3-stage continuous-culture system human colon 
simulator (Maccaferri, Klinder, Brigidi, Cavina, & Costabile, 2012). The 
effects of the lactic yeast K. marxianus B0399 on adhesion and immune 
mediator’s production (i.e. cytokines, chemokines and growth factors) 
on Caco-2 cells and peripheral blood mononuclear cells (PBMCs) were 
also studied. The results showed an increase of bifidobacteria concen-
tration in the colonic model system when in contact with K. marxianus 
B0399, together with an increase in the SCFA acetate and propionate 
concentrations. K. marxianus adhesion on Caco-2 cells increased and 
K. marxianus B0399 provoked an increase in the levels of production of 
proinflammatory cytokines in PBMCs. 
The in vitro models effectiveness on the study of metabolic and 
immunological responses induced by host-probiotic interactions and 
prebiotic fermentation, depends on in vitro cultures of human intestinal 
epithelial cell lines jointly with complex bacterial communities (Mar-
zorati et al., 2011). These models can offer valuable data on host re-
sponses to colon fermentation, bacteria adhesion and immune 
modulatory activity of prebiotics and probiotics (Moon, Li, Bang, & Han, 
2016). Although, research studies are limited in this field, some have 
assessed the host response factors through the combination of in vitro 
colon microbiota cultures and human intestinal cell models (i.e. 
microbiome-host interaction models). For example, Arboleya et al. 
(2015) examined the immune response modulation by two probiotic 
Bifidobacterium species (Bifidobacterium bifidum IPLA 20015 and Bifi-
dobacterium breve IPLA 20005) in a single-stage continuous-culture 
system inoculated with infant faeces combined with HT-29 epithelial 
cells. This study showed that B. breve promoted higher levels of cytokine 
formation by HT-29 cells than B. bifidum. The authors considered that 
fermentation combined with HT-29 cells could be a tool to probiotic 
potential screening of various bacterial species (Arboleya et al., 2015). 
On another study, the effects of prebiotics arabinogalactan (AG) and 
FOS were assessed in the SHIME, inoculated with faecal material from a 
patient with inflammatory bowel disease, coupled with co-cultures of 
Caco-2 cells and macrophages (THP1) (Daguet, Pinheiro, Verhelst, 
Possemiers, & Marzorati, 2016). FOS and AG showed a different 
fermentation profile in the proximal and distal colon, respectively, and 
both prebiotics had a positive effect on gut barrier and inflammation. 
Moreover, AG results showed a significantly higher TEER of Caco-2 cells 
monolayers, AG decreased the nuclear factor (NF)-κB activity, and 
increased the IL-10 production. Recently, Greenhalgh et al. (2019) used 
the HuMiX model to assess metabolic and immune responses in human 
colorectal cancer cells (Caco-2) after co-culturing with a probiotic (LGG) 
under a simulated high-fibre diet (prebiotic regimen). These authors 
demonstrated that this symbiotic regimen led to a downregulation of 
Caco-2-associated signalling pathways and oncogenes expression, and 
attenuated Caco-2 self-renewal ability. 
As can be seen from the research outcomes mentioned above, com-
bined and continuous in vitro host-microbiota models are a viable plat-
form for evaluating host-microbiota responses to prebiotic and probiotic 
fermentation processes. 
5. Conclusions 
Current existing models can be distinguished considering two main 
approaches: 1) the continuous bioreactors targeted to complex human 
microbiota cultivation; and 2) microfluidic devices operating under 
continuous medium flow and co-culture of representative bacteria and 
human cells. Existing models have been designed according to questions 
intended to address, e.g. assess the biochemical profile of diet- 
microbiota relationship or the biological profile of microbiota-host 
interface. Although these models present different degrees of 
complexity, none of them is able to simultaneously cover all the key 
conditions found within the human colon. Thus, there is still a signifi-
cant opportunity to further improve the experimental in vitro setups 
accuracy and realism. New setups are required to provide comprehen-
sive simulation of anatomical, physical, biochemical and biological 
conditions found within the human gut to better study its microbiota. 
The development of sequential modules that simulate all microbiome- 
host interactions levels – i.e. food digestion, microbiota fermentation, 
biochemical cross-talk, intestine cells behaviour and host response – is of 
utmost importance. 
New solutions that cover the drawbacks mentioned are needed to 
bring new insights into the interplay between gut microbiota and host 
health. These novel approaches will improve the development of new 
functional foods and nutraceuticals, introduce new therapeutic strate-
gies for colon diseases, and help to consolidate the pivotal role of 
microbiome on human health. 
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Smidt, H., … Venema, K. (2009). Linking phylogenetic identities of bacteria to starch 
fermentation in an in vitro model of the large intestine by RNA-based stable isotope 
probing. Environmental Microbiology, 11(4), 914–926. https://doi.org/10.1111/ 
j.1462-2920.2008.01815.x 
Labarthe, S., Polizzi, B., Phan, T., Goudon, T., Ribot, M., & Laroche, B. (2019). 
A mathematical model to investigate the key drivers of the biogeography of the 
colon microbiota. Journal of Theoretical Biology, 462, 552–581. https://doi.org/ 
10.1016/j.jtbi.2018.12.009 
Liang, D., Leung, R. K. K., Guan, W., & Au, W. W. (2018). Involvement of gut microbiome 
in human health and disease: Brief overview, knowledge gaps and research 
opportunities. Gut Pathogens, 10(1), 1–9. https://doi.org/10.1186/s13099-018- 
0230-4 
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012). 
Diversity, stability and resilience of the human gut microbiota. Nature, 489(7415), 
220–230. https://doi.org/10.1038/nature11550 
Maccaferri, S., Klinder, A., Brigidi, P., Cavina, P., & Costabile, A. (2012). Potential 
probiotic Kluyveromyces marxianus B0399 modulates the immune response in Caco-2 
cells and peripheral blood mononuclear cells and impacts the human gut microbiota 
in an in vitro colonic model system. Applied and Environmental Microbiology, 78(4), 
956–964. https://doi.org/10.1128/aem.06385-11 
Macfarlane, G. T., Cummings, J. H., Macfarlane, S., & Gibson, G. R. (1989). Influence of 
retention time on degradation of pancreatic enzymes by human colonic bacteria 
grown in a 3-stage continuous culture system. Journal of Applied Bacteriology, 67(5), 
521–527. https://doi.org/10.1111/j.1365-2672.1989.tb02524.x 
Macfarlane, G. T., Macfarlane, S., & Gibson, G. R. (1998). Validation of a three-stage 
compound continuous culture system for investigating the effect of retention time on 
the ecology and metabolism of bacteria in the human colon. Microbial Ecology, 35(2), 
180–187. https://doi.org/10.1007/s002489900072 
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